background
neurolog
diseas
becom
obviou
challeng
due
insuffici
therapeut
intervent
therefor
novel
drug
variou
neurolog
disord
desper
need
recent
compel
evid
demonstr
chemokin
receptor
g
proteincoupl
receptor
cxc
chemokin
receptor
famili
may
play
pivot
role
develop
neurolog
diseas
aim
review
provid
evid
potenti
therapeut
target
neurolog
diseas
english
journal
articl
focus
invovl
neurolog
diseas
search
via
pubm
may
moreov
refer
list
identifi
articl
includ
overview
express
level
cell
significantli
elev
sever
neurolog
diseas
includ
multipl
sclerosi
ms
glioma
alzheim
diseas
ad
chronic
pain
human
tlymphotrop
viru
type
myelopathytrop
spastic
paraparesi
hamtsp
bipolar
disord
antagonist
show
therapeut
effect
neurolog
diseas
studi
provid
hard
evid
play
vital
role
pathogenesi
ms
glioma
ad
chronic
pain
hamtsp
bipolar
disord
crucial
molecul
neuroinflammatori
neurodegen
diseas
regul
activ
infiltr
cell
resid
immun
cell
howev
exact
function
neurolog
diseas
inconclus
thu
import
understand
topic
chemokin
scope
activ
neurolog
diseas
substanti
prolong
averag
life
expect
preval
neurolog
diseas
increas
markedli
past
decad
lead
becom
major
public
health
problem
unfortun
drug
current
avail
cure
diseas
thu
new
drug
variou
neurolog
disord
desper
need
chemokin
import
modul
neuroinflamm
neurodegen
process
small
protein
import
activ
migrat
address
correspond
author
cancer
center
tongji
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
wuhan
china
tel
fax
email
gmailcom
depart
obstetr
gynecolog
tongji
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
wuhan
china
tel
fax
email
dellax
immun
cell
lesion
site
chemokin
receptor
belong
cxc
chemokin
receptor
famili
g
proteincoupl
receptor
play
vital
role
mediat
chemotact
migrat
cell
prolifer
surviv
mainli
express
variou
effector
lymphocyt
includ
cell
cytotox
cell
natur
killer
nk
cell
principl
chemokin
ligand
plateletderiv
ligand
weakli
chemotact
neutrophil
monocyt
fibroblast
mainli
induc
interferon
gamma
potent
chemoattract
monocyt
cell
nk
cell
dendrit
cell
although
share
chemokin
receptor
three
ligand
regul
uniqu
promot
exhibit
distinct
tempor
spatial
express
pattern
tabl
recent
studi
shown
chemokin
receptor
express
central
nervou
system
cn
diseas
involv
pathogenesi
shown
express
level
ligand
elev
peripheri
blood
cerebrospin
fluid
csf
patient
neurolog
diseas
correl
prognosi
certain
case
addit
treatment
antagonist
could
allevi
bone
cancer
pain
bcp
induc
mechan
allodynia
studi
suggest
import
role
neurolog
diseas
indic
target
may
reveal
novel
therapeut
intervent
manag
neurolog
diseas
thu
summar
current
evid
support
role
pathogenesi
neurolog
diseas
includ
multipl
sclerosi
glioma
alzheim
diseas
chronic
pain
human
tlymphotrop
viru
type
myelopathi
multipl
sclerosi
ms
also
known
dissemin
sclerosi
chronic
inflammatori
diseas
cn
character
destruct
myelin
oligodendrocyt
brain
spinal
cord
mount
evid
suggest
play
vital
part
ms
balashov
et
al
first
report
posit
cell
increas
blood
relapsingremit
progress
ms
compar
control
also
found
one
ligand
express
astrocyt
ms
brain
lesion
unaffect
white
matter
control
ms
subject
result
suggest
express
level
may
use
immunolog
stage
ms
provid
rational
use
agent
block
therapeut
approach
treatment
ms
use
immunocytochemistri
simpson
et
al
confirm
express
receptor
postmortem
cn
tissu
ms
case
differ
stage
lesion
develop
result
show
macrophag
astrocyt
activ
demyelin
lesion
predominantli
express
express
cell
astrocyt
within
plaqu
differenti
express
chemokin
indic
block
chemokin
receptor
may
serv
antiinflammatori
therapi
ms
hand
significantli
increas
csf
patient
ms
compar
control
moreov
increas
level
associ
clinic
relaps
ms
compar
secondari
progress
ms
concentr
significantli
greater
patient
relapsingremit
correl
significantli
express
csf
cell
patient
ms
anoth
studi
sindern
et
al
demonstr
increas
level
posit
tcell
csf
strongli
associ
activ
mri
lesion
appear
patient
relapsingremit
ms
might
result
migrat
activ
tcell
circul
csf
consist
previou
report
studi
confirm
hypothesi
might
involv
develop
acut
ms
lesion
lead
therapeut
intervent
via
block
analyz
express
peripher
lymphocyt
ms
patient
mahad
et
al
found
increas
express
peripher
blood
lymphocyt
associ
relaps
fluctuat
express
significantli
greater
patient
ms
control
studi
provid
evid
potenti
therapeut
valu
antagonist
therapeut
effect
patient
ms
well
establish
treatment
three
month
sorensen
et
al
found
express
cell
significantli
reduc
wherea
express
receptor
eg
unalt
result
indic
may
exert
therapeut
effect
ms
patient
suppress
express
experiment
autoimmun
encephalomyel
eae
rodent
model
human
ms
celland
cellmedi
demyelin
diseas
cn
role
eae
wide
studi
consid
ligand
elev
ms
patient
propos
block
neutral
ligand
would
inhibit
develop
eae
howev
narumi
et
al
report
eae
rat
treat
monoclon
antibodi
mab
exacerb
diseas
score
less
enlarg
drain
lymph
node
treat
control
mab
smaller
drain
lymph
node
eae
rat
treat
mab
might
explain
follow
mechan
neutral
caus
increas
releas
cell
lymph
node
result
increas
migrat
cn
anoth
ligand
induc
well
moreov
mice
exhibit
reduc
threshold
eae
induct
develop
sever
eae
immun
low
dose
myelin
oligodendrogli
glycoprotein
mog
produc
minim
diseas
wildtyp
litterm
anoth
studi
muller
et
al
examin
function
signal
eae
use
defici
mice
signific
differ
found
term
time
onset
peak
diseas
sever
wildtyp
wt
mice
howev
mice
sever
chronic
diseas
increas
demyelin
axon
damag
addit
inflammatori
lesion
widespread
throughout
cn
mice
wt
mice
inflammatori
lesion
consist
welldemarc
perivascular
mononuclear
cell
infiltr
furthermor
regulatori
cell
significantli
reduc
number
scatter
spinal
cord
mice
result
suggest
signal
play
major
protect
role
eae
constrain
cell
perivascular
space
cn
promot
regulatori
cell
accumul
facilit
interact
cell
effector
cell
thu
limit
autoimmunemedi
tissu
damag
mous
model
neurotrop
coronavirusinduc
encephalomyel
marqu
et
al
found
accumul
antibodi
secret
cell
asc
cn
mediat
mice
total
virusspecif
asc
reduc
greater
furthermor
neither
virusspecif
asc
traffick
bone
marrow
antivir
serum
antibodi
reduc
rel
level
control
mice
addit
infect
mice
show
elev
level
persist
viral
rna
sustain
infecti
viru
increas
clinic
diseas
mortal
result
indic
play
vital
role
recruit
activ
asc
inflam
cn
highlight
protect
role
persist
infect
studi
demonstr
critic
recruit
asc
cn
vasculatur
asc
entri
cn
parenchyma
mous
model
viral
encephalomyel
studi
found
reduc
cn
igg
chain
mrna
virusspecif
ab
well
impair
asc
recruit
rather
mice
moreov
asc
recruit
cn
mice
restrict
vasculatur
wherea
local
parenchyma
wildtyp
mice
recent
axi
also
demonstr
role
recruit
pathogen
lymphocyt
brain
patient
rasmussen
enceph
use
surgic
specimen
children
rasmussen
enceph
found
express
cytotox
lymphocyt
infiltr
damag
area
primari
biopsi
wherea
express
neuron
astrocyt
area
addit
vitro
studi
demonstr
astrocyt
upregul
mrna
express
level
releas
supernat
respons
infect
complet
abolish
antagonist
result
suggest
astrocyt
neuron
may
recruit
pathogen
lymphocyt
area
brain
rasmussen
enceph
axi
conclud
clinic
studi
provid
compel
evid
involv
develop
ms
antagonist
may
becom
novel
agent
manag
ms
howev
studi
larger
sampl
size
longer
followup
warrant
investig
feasibl
antagonist
exact
mechan
allevi
ms
anim
studi
also
propos
protect
role
eae
may
provid
novel
insight
intervent
strategi
howev
underli
mechan
exert
protect
role
eae
need
investig
glioma
account
major
neoplasm
occur
cn
one
aggress
type
human
cancer
report
regul
cell
invas
migrat
facilit
tumor
metastasi
lymph
node
furthermor
express
level
correl
prognosi
breast
cancer
colorect
cancer
renal
cell
cancer
maru
et
al
first
report
increas
glioma
cell
compar
adult
human
astrocyt
moreov
found
express
level
correl
malign
grade
glioma
glioblastoma
multiform
gbm
aggress
form
human
glioma
mean
surviv
approxim
month
despit
intens
comprehens
treatment
liu
et
al
examin
role
gbm
progress
use
murin
model
malign
glioma
found
murin
glioma
cell
express
vitro
tumor
express
vivo
mice
glioma
significantli
shorter
median
surviv
time
reduc
number
tumorinfiltr
natur
killer
nk
natur
killer
nkt
cell
contrast
wt
glioma
mice
howev
treatment
antagonist
suppress
tumor
growth
increas
median
surviv
time
tumorbear
wt
mice
compar
vehicletr
group
suggest
may
inhibitori
effect
directli
tumor
cell
moreov
impact
tumorinfiltr
nk
nkt
cell
known
express
suggest
primari
mean
nk
nkt
cell
traffic
glioma
thu
absenc
tumorinfiltr
nk
nkt
cell
rather
may
account
shorter
surviv
time
tumorbear
mice
moreov
ligand
express
murin
human
glioma
cell
line
result
suggest
system
may
uniqu
target
human
gbm
therapi
recent
pu
et
al
investig
potenti
prognost
valu
primari
gbm
relationship
clinicopatholog
featur
use
kaplanmei
surviv
curv
analysi
logrank
comparison
primari
gbm
patient
found
patient
higher
express
level
shorter
progress
free
surviv
overal
surviv
compar
lower
express
level
use
univari
cox
regress
analysi
found
high
express
risk
factor
primari
gbm
p
hazard
ratio
hr
confid
interv
ci
furthermor
multivari
cox
regress
analysi
show
express
level
independ
prognost
factor
overal
surviv
primari
gbm
patient
taken
togeth
result
suggest
might
use
independ
prognost
biomark
primari
gbm
patient
alzheim
diseas
ad
one
preval
progress
neurodegen
brain
disord
worldwid
character
loss
neuron
synaps
cerebr
cortex
certain
subcort
region
chemokin
receptor
found
associ
ad
patholog
chang
use
postmortem
human
tissu
ad
patient
xia
et
al
provid
first
immunohistochem
evid
constitut
express
subpopul
neuron
neuron
process
neocortex
hippocamp
format
striatum
cerebellum
spinal
cord
moreov
found
greatli
upregul
posit
astrocyt
ad
patient
compar
control
addit
posit
astrocyt
frequent
associ
amyloid
deposit
suggest
activ
chronic
inflammatori
respons
relat
amyloid
deposit
occur
ad
patient
recent
krauthausen
et
al
examin
impact
amyloid
precursor
protein
app
presenilin
transgen
mous
model
ad
found
amyloid
beta
deposit
level
significantli
decreas
mice
compar
control
mice
vitro
vivo
analysi
microgli
phagocytosi
show
defici
facilit
microgli
uptak
moreov
preincub
antagonist
increas
primari
microgli
phagocytosi
reduc
secret
compar
control
mice
brain
tissu
mice
reduc
concentr
proinflmmatori
cytokin
microglia
exhibit
obviou
morpholog
activ
reduc
plaqu
associ
furthermor
morri
watermaz
test
show
improv
spatial
memori
mice
compar
control
suggest
lack
attenu
behavior
deficit
mice
taken
togeth
result
indic
signal
mediat
develop
adlik
patholog
mice
suggest
potenti
therapeut
target
ad
furthermor
recent
studi
report
peripher
blood
mononuclear
cell
alzheim
diseas
patient
control
level
human
blood
brain
barrier
model
studi
indic
pivot
role
pathogenesi
ad
howev
studi
warrant
explor
underli
mechan
pain
play
vital
role
protect
us
damag
stimuli
howev
chronic
pain
present
major
challeng
due
complex
natur
histori
unclear
etiolog
poor
respons
therapi
compel
evid
support
involv
neuroinflamm
chronic
pain
lab
investig
mechan
chronic
pain
decad
previous
shown
involv
signal
bcp
rat
model
intratibi
inocul
walker
mammari
gland
carcinoma
cell
bcp
model
establish
indic
downregul
paw
withdraw
threshold
pwt
bone
destruct
realtim
polymeras
chain
reaction
pcr
immunohistochem
analys
show
receptor
upregul
spinal
cord
bcp
rat
block
signal
via
antibodi
antagonist
prevent
develop
bcp
microgli
activ
moreov
inhibit
microgli
activ
attenu
upregul
bcp
rat
result
suggest
signal
particip
bcp
via
activ
microglia
rat
model
studi
reveal
cellular
mechan
mediat
bcp
confirm
significantli
increas
spinal
cord
bcp
rat
coloc
either
neuron
microglia
astrocyt
spinal
cord
nonpeptiderg
peptiderg
atyp
neuron
dorsal
root
ganglion
drg
moreov
spinal
phosphoryl
akt
extracellular
signalregul
kinas
markedli
upregul
bcp
rat
timedepend
manner
meanwhil
coloc
either
pakt
blockag
either
akt
attenu
mechan
allodynia
bcp
rat
furthermor
antagonist
suppress
upregul
pakt
taken
togeth
result
indic
activ
spinal
chemokin
receptor
mediat
bcp
akterk
pathway
recent
studi
perform
jiang
et
al
confirm
pivot
role
neuropath
pain
found
express
significantli
upregul
mainli
spinal
neuron
follow
spinal
nerv
ligat
snl
moreov
ligand
also
consider
increas
spinal
neuron
astrocyt
snl
mice
addit
inhibit
express
shrna
target
sequenc
mice
well
antagonist
attenu
snlinduc
mechan
allodynia
thermal
hyperalgesia
importantli
reveal
epigenet
mechan
contribut
neuropath
pain
result
suggest
target
may
allevi
establish
choric
pain
novel
antagonist
fewer
side
effect
develop
human
tlymphotrop
viru
type
associ
myelopathytrop
spastic
paraparesi
hamtsp
rare
neurodegen
diseas
character
chronic
inflamm
spinal
cord
recent
ando
et
al
investig
possibl
role
signal
chronic
inflamm
hamtsp
found
express
level
markedli
high
csf
hamtsp
patient
great
deal
csf
cell
express
receptor
mainli
consist
cell
small
popul
cell
immunofluoresc
result
show
astrocyt
major
produc
spinal
cord
hamtsp
patient
cocultur
human
astrocytoma
cell
cell
hamtsp
patient
reveal
astrocyt
produc
respons
secret
cell
moreov
chemotaxi
assay
result
suggest
induc
migrat
peripher
blood
mononuclear
cell
cn
neutral
antibodi
could
disrupt
migrat
result
demonstr
infect
cell
cn
produc
induc
astrocyt
secret
recruit
infect
cell
area
via
constitut
helper
type
posit
feedback
loop
result
chronic
inflamm
bipolar
disord
bd
sever
disord
high
preval
affect
mood
cognit
function
pathophysiolog
remain
larg
unknown
emerg
line
evid
shown
associ
bd
immun
system
brietzk
et
al
first
examin
serum
chemokin
level
bd
patient
compar
result
obtain
healthi
subject
found
serum
level
increas
level
decreas
bd
patient
contrast
control
suggest
associ
bd
chang
chemokin
level
worth
mention
eotaxin
bind
recruit
eosinophil
cell
also
act
antagonist
barbosa
et
al
investig
plasma
level
chemokin
bd
patient
differ
neuropsychiatri
state
euthymia
mania
compar
healthi
control
result
show
bd
patient
increas
plasma
level
decreas
plasma
level
contrast
healthi
control
moreov
chemokin
level
significantli
differ
bd
patient
euthymia
mania
furthermor
logist
regress
stress
main
effect
increas
plasma
level
decreas
plasma
level
bd
studi
indic
receptor
investig
regard
potenti
role
longstand
marker
bd
review
current
evid
discuss
possibl
involv
neurolog
diseas
studi
provid
hard
evid
play
vital
role
pathogenesi
ms
glioma
ad
chronic
pain
hamtsp
bipolar
disord
crucial
molecul
neuroinflammatori
neurodegen
diseas
regul
activ
infiltr
cell
resid
immun
cell
howev
exact
function
neurolog
diseas
inconclus
thu
import
understand
topic
chemokin
scope
activ
neurolog
diseas
studi
focus
chemokin
neurolog
diseas
may
lead
discoveri
novel
therapeut
strategi
patient
suffer
variou
neurolog
disord
connect
neuroinflamm
worth
mention
caution
must
taken
consid
therapeut
target
sinc
mediat
benefici
harm
effect
cours
cn
diseas
applic
author
declar
conflict
interest
financi
otherwis
